Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2025-12-30

Clinical Trial Update: Contrast-enhanced Ultrasound for Sentinel Node Detection [Phase 2, Phase 3]

View source ↗

Summary

A Phase 2/Phase 3 clinical trial sponsored by The Netherlands Cancer Institute is evaluating contrast-enhanced ultrasound for sentinel lymph node detection in m…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: The Netherlands Cancer Institute | Conditions: Melanoma, Breast Cancer | Phase 2, Phase 3 | Status: RECRUITING